Axon's 9-Year Winning Streak Just Snapped. Can It Get Back on Track in 2026?

Axon Enterprise saw its decade-long streak of annual gains end as the stock fell 4% in 2025, after a late-2024 surge left valuation stretched (price-to-sales rising from ~4 to ~19). The business, however, remains strong: management raised 2025 revenue guidance to $2.74 billion (implying ~31% YoY growth) and the company has posted revenue growth above 30% in seven straight quarters and 14 of the last 15. Strategic acquisitions (Prepared and Carbyne) expanded TAM by $5 billion to $159 billion and enabled AI-driven products such as Axon 911 and Draft One, supporting a bullish long-term growth thesis despite near-term valuation headwinds.

Analysis

Market structure: Axon (AXON) sits on a widening moat—hardware + recurring SaaS (evidence/records/911) —so winners are recurring-revenue software vendors and AI-integration partners while legacy one-off hardware vendors and pure camera makers face margin pressure. Pricing power has improved (package-deal sales, commercial expansion into delivery fleets) which can sustain higher gross margins; supply constraints are minimal but demand will be lumpy because public procurement cycles and large enterprise deals dominate flows. Cross-asset: continued high growth and valuation (P/S ~19) increases equity vol and option premia; a negative execution surprise would push risk-free flows into bonds and slightly strengthen USD on risk-off, with negligible commodity impact.

Risk assessment: Key tail risks are regulatory (privacy/face-recognition bans), AI-liability lawsuits, and failed M&A integrations (Prepared/Carbyne) that could mute the $159B TAM realization; a single large municipal procurement reversal could create a 15-25% quarter-over-quarter revenue shock. Time horizons: days—volatility spikes on guidance/macro; weeks–months—proof points from Axon 911 and Draft One monetization; quarters–years—TAM capture and ARR re-rating. Hidden dependencies include federal/state grant cycles and law-enforcement budget trends; catalysts that accelerate rerating are visible SaaS ARR growth and commercial adoption outside policing.

Trade implications: Direct: asymmetric long exposure to AXON sized 1.5–3% of portfolio with defined hedges; pair trades: long AXON vs short legacy public-safety hardware (e.g., MSI) to isolate growth premium. Options: buy 9–12 month calls on pullbacks or implement 6–9 month put spreads as insurance (limit downside ~12–20% net). Sector rotation: overweight AI/enterprise SaaS (e.g., NVDA exposure for infrastructure) and underweight legacy hardware; act into 10–25% intra-year pullbacks or on two consecutive quarters of top-line upside surprises.

Key Decisions for Investors

• Establish a 2–3% long core position in AXON (AXON) on either a 15–25% pullback from current levels or immediately on confirmation of two consecutive quarters (next 2 quarters) of revenue >30% YoY and ARR growth acceleration; target 12-month upside 30–50% if guidance/ARR beats persist.
• Hedge existing AXON exposure by buying 3-month puts 10% OTM sized to cover 50% of the position, or alternatively buy a 6-month 10%/25% OTM put spread to cap downside while limiting premium outlay (expected max loss ~12–15% of hedge cost).
• Implement a pair trade: long AXON (1.5% portfolio) vs short Motorola Solutions (MSI) (1.5%) to capture growth vs legacy exposure; rebalance quarterly and unwind if AXON underperforms MSI by >15% over any 90-day window or if AXON misses revenue guide two quarters in a row.
• If capital-light bullish: buy 9–12 month at-the-money (or up to 30% OTM if funding constrained) LEAPS/calls on AXON after a >10% intraday pullback and finance by selling 3–6 month covered calls on 25% of the long to generate premium; reassess after next two quarterly reports.
• Shift 2–4% of portfolio weight from legacy hardware/public-safety suppliers into AI/enterprise SaaS exposure (e.g., incremental NVDA or high-quality SaaS names) over the next 30–60 days to capture secular AI tailwinds and neutralize public-procurement cyclicality risk.